LGVN
Longeveron Inc - Ordinary Shares - Class A

12,989
Mkt Cap
$20.77M
Volume
129,888.00
52W High
$1.92
52W Low
$0.475
PE Ratio
-0.73
LGVN Fundamentals
Price
$0.9735
Prev Close
$0.809
Open
$0.851
50D MA
$0.582
Beta
0.96
Avg. Volume
438,963.23
EPS (Annual)
-$2.62
P/B
2.06
Rev/Employee
$92,000.00
$1.50
Loading...
Loading...
News
all
press releases
News Placeholder
Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal
Longeveron shares are trading sharply higher Tuesday afternoon following the announcement of a private placement agreement worth up to $30 million.read more...
Benzinga·6d ago
News Placeholder
Best Biotech Stocks To Keep An Eye On - March 10th
Vertex Pharmaceuticals, BioNTech, Danaher, Longeveron, Moderna, United Therapeutics, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·6d ago
News Placeholder
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study
Longeveron said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo.
Stocktwits·19d ago
<
...
1
>

Latest LGVN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.